Make a 2024 Plan for Weight Loss and Diabetes Medications

Wednesday, November 15, 2023


Make a 2024 Plan for Weight Loss and Diabetes Medications

If you are among the 43% of employers considering coverage of GLP-1s for weight loss like Wegovy and diabetes medication, Ozempic, next year, you need a strategy for rolling them out to your workforce. Who should qualify for coverage?  How can you monitor safe and effective use? Will you need to adjust your population health targets?

In this session Accolade physician leaders provide clinical guidance on bringing GLP-1s into your organization. 

Learning objectives:

- Obtain perspective on the true cost of chronic conditions like diabetes and obesity. 

- Understand primary care’s critical role in a holistic care approach and the safe prescription of medications.

- Learn the key considerations primary care physicians use to diagnose diabetes and obesity and decide if GLP-1s would be a helpful medication. 

- How to appropriately set goals and expectations beyond the medication when it comes to a patient-centered support model.


From Day One is a Recertification Provider for SHRM and HRCI. This session is eligible for 1 PDC. The Activity ID will be sent to attendees after the conclusion of the session.

This session is hosted by the From Day One editorial team with support from Accolade.